Status:

COMPLETED

Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine

Lead Sponsor:

Taipei Medical University Hospital

Collaborating Sponsors:

National Health Research Institutes, Taiwan

Conditions:

Schizophrenia

Eligibility:

All Genders

18-60 years

Phase:

PHASE4

Brief Summary

Clozapine has been virtually the only psychopharmacological choice in patients with schizophrenia who either did not response to typical neuroleptics or experienced severe extrapyramidal side effects ...

Detailed Description

Background Schizophrenia is one of the most severe mental illnesses. The prevalence of schizophrenia has been variously reported as ranging from 1 to 1.5 percent. More than 50% of patients can be desc...

Eligibility Criteria

Inclusion

  • Inpatients meet the DSM-IV criteria for schizophrenia.
  • Treatment refractoriness: Failed to respond to at least two typical neuroleptics at dosage equivalent to or greater than 1000 mg/day of chlorpromazine for a period of at least six weeks.
  • Age 18-60 years.
  • Males or females.
  • Total PANSS score \>60
  • Good physical health determined by complete physical examination, laboratory tests, and EKG.
  • Capacity and willingness to give written informed consent.

Exclusion

  • History of illicit substance abuse or dependence
  • History of clozapine intolerance (such as clinically significant leukopenia or agranulocytosis).
  • Patients with WBC count less than 3500/mm3 or ANC count less than 2000/mm3will not be included.
  • Any depot neuroleptics within 30 days before the day of randomization.
  • Epilepsy, active hepatitis, HIV positivity, or current myeloproliferative disorder. Other medical illnesses may necessitate subjects' exclusion after evaluation of individual cases by the principal investigator and other staffs. Clinical judgment will be used.

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT01401491

Start Date

January 1 2008

End Date

December 1 2010

Last Update

July 25 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Taipei Medical University-Wan Fang Hospital

Taipei, Taiwan, 116

Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine | DecenTrialz